Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART vs Fixed Dose Treatment in COPD
NCT02477397Phase 3Unknown
- Sponsor
- University Medical Center Groningen
- Start
- May 2015
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide, formoterol in chronic obstructive pulmonary disease (COPD), sponsored by University Medical Center Groningen. Status: unknown.
02
Drugs
budesonideformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02477397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02477397.